Kiener Peter A
CIK 0001328146
Director
Filings
10
Latest Jan 6, 2026
Issuers covered
3
Showing
10 of 10
Page 1
Track record
1 of 1 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 1 | 0% | -13.0% | -13.0% | -13.0% | -13.0% |
| 90 days | 1 | 0% | -16.1% | -16.1% | -16.1% | -16.1% |
| 180 days | 1 | 100% | +28.5% | +28.5% | +28.5% | +28.5% |
| 365 days | 1 | 100% | +42.4% | +42.4% | +42.4% | +42.4% |
Issuers
Companies where Kiener Peter A has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| CUE | Cue Biopharma, Inc. | 6 | Jan 6, 2026 |
| LVTX | Lava Therapeutics NV | 2 | Nov 17, 2025 |
| PIRS | Pieris Pharmaceuticals, Inc. | 2 | Jun 23, 2023 |
All filings
10 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|